Literature DB >> 23378129

Recurrent seizures and serotonin syndrome following "2C-I" ingestion.

Adam Bosak1, Frank LoVecchio, Michael Levine.   

Abstract

The phenethylamines, including 2, 5 dimethoxy-4-iodophenethylamine, commonly referred to as 2C-I, have recently emerged as a new class of designer drugs. Cases of toxicity from these drugs are not well described in the literature. This case report describes a 19 year-old male who insufflated 2C-I. Following the ingestion, the patient developed recurrent seizures, and was taken to the emergency department, where he was noted to be hyperadrenergic and had recurrent seizures. The patient was diagnosed with serotonin syndrome and experienced prolonged respiratory failure, although he ultimately made a full recovery. Comprehensive drug testing revealed the presence of 2C-I. The pharmacologic properties of 2C-I are also discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23378129      PMCID: PMC3657032          DOI: 10.1007/s13181-013-0287-x

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  12 in total

1.  More data about the new psychoactive drug 2C-B.

Authors:  D de Boer; M J Gijzels; I J Bosman; R A Maes
Journal:  J Anal Toxicol       Date:  1999 May-Jun       Impact factor: 3.367

2.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Authors:  E J C Dunkley; G K Isbister; D Sibbritt; A H Dawson; I M Whyte
Journal:  QJM       Date:  2003-09

Review 3.  Chemistry, pharmacology, and metabolism of emerging drugs of abuse.

Authors:  Hans H Maurer
Journal:  Ther Drug Monit       Date:  2010-10       Impact factor: 3.681

Review 4.  The serotonin syndrome.

Authors:  Edward W Boyer; Michael Shannon
Journal:  N Engl J Med       Date:  2005-03-17       Impact factor: 91.245

5.  New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques.

Authors:  Denis S Theobald; Michael Pütz; Erhard Schneider; Hans H Maurer
Journal:  J Mass Spectrom       Date:  2006-07       Impact factor: 1.982

6.  The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.

Authors:  Fumiko Nagai; Ryouichi Nonaka; Kanako Satoh Hisashi Kamimura
Journal:  Eur J Pharmacol       Date:  2006-12-12       Impact factor: 4.432

7.  [125I]-2-(2,5-dimethoxy-4-iodophenyl)aminoethane ([125I]-2C-I) as a label for the 5-HT2 receptor in rat frontal cortex.

Authors:  M P Johnson; C A Mathis; A T Shulgin; A J Hoffman; D E Nichols
Journal:  Pharmacol Biochem Behav       Date:  1990-01       Impact factor: 3.533

8.  Identification of monoamine oxidase and cytochrome P450 isoenzymes involved in the deamination of phenethylamine-derived designer drugs (2C-series).

Authors:  Denis S Theobald; Hans H Maurer
Journal:  Biochem Pharmacol       Date:  2006-09-24       Impact factor: 5.858

9.  A fatal poisoning involving Bromo-Dragonfly.

Authors:  Mette Findal Andreasen; Rasmus Telving; Rune Isak Dupont Birkler; Bente Schumacher; Mogens Johannsen
Journal:  Forensic Sci Int       Date:  2008-12-17       Impact factor: 2.395

10.  Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors.

Authors:  Claudio Acuña-Castillo; Claudio Villalobos; Pablo R Moya; Patricio Sáez; Bruce K Cassels; J Pablo Huidobro-Toro
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

View more
  8 in total

1.  Novel psychoactive substances of interest for psychiatry.

Authors:  Fabrizio Schifano; Laura Orsolini; G Duccio Papanti; John M Corkery
Journal:  World Psychiatry       Date:  2015-02       Impact factor: 49.548

2.  Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

3.  Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.

Authors:  Joshua S Elmore; Ann M Decker; Agnieszka Sulima; Kenner C Rice; John S Partilla; Bruce E Blough; Michael H Baumann
Journal:  Neuropharmacology       Date:  2018-03-01       Impact factor: 5.250

Review 4.  Legal highs: staying on top of the flood of novel psychoactive substances.

Authors:  David Baumeister; Luis M Tojo; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2015-04

5.  Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function.

Authors:  Amy J Eshleman; Michael J Forster; Katherine M Wolfrum; Robert A Johnson; Aaron Janowsky; Michael B Gatch
Journal:  Psychopharmacology (Berl)       Date:  2013-10-19       Impact factor: 4.530

6.  Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances.

Authors:  Valeria Sogos; Paola Caria; Clara Porcedda; Rafaela Mostallino; Franca Piras; Cristina Miliano; Maria Antonietta De Luca; M Paola Castelli
Journal:  Int J Mol Sci       Date:  2021-06-24       Impact factor: 5.923

Review 7.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

8.  Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders.

Authors:  Deborah Dal Farra; Alice Valdesalici; Giancarlo Zecchinato; Alfio De Sandre; Diego Saccon; Pierluigi Simonato; Ornella Corazza; Giovanni Martinotti; Andrew L Smith; Marco Solmi
Journal:  Int J Environ Res Public Health       Date:  2022-01-14       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.